My SciELO
Services on Demand
Article
Indicators
- Cited by SciELO
Related links
- Similars in SciELO
Share
Revista Cubana de Hematología, Inmunología y Hemoterapia
Print version ISSN 0864-0289
Abstract
JAIME-FAGUNDO, Juan Carlos; FORRELLAT-BARRIOS, Mariela and ARENCIBIA-NUNEZ, Alberto. Hematological emergencies. III. Methotrexate toxicity. Rev Cubana Hematol Inmunol Hemoter [online]. 2012, vol.28, n.3, pp. 246-252. ISSN 0864-0289.
Methotrexate is an antimetabolite which competitively inhibits the dihydrofolate reductase enzyme and has anti-proliferative and immunosuppressive activity and therefore it is used in the treatment of various hematological malignancies. The main adverse effects are myelosuppression, renal insufficiency, mucositis and neurological disorders. The adequate management of intoxication by this drug is very important since fast and appropriate actions can reverse the damage and save the patient's life. A review of the behaviour against acute toxicity by this drug is reported.
Keywords : methotrexate; folinic acid; toxicity; mucositis; adverse reactions; neurotoxicity; glucarpidase.